Patent details

Basic Information

Publication number:

EP3655017

PCT Application Number:

EP2018069439

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP187592548

PCT Publication Number:

WO2019016233

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

17/07/2018

Grant date:

22/01/2025

EP Publication Date:

27/05/2020

PCT Publication Date:

24/01/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/01/2025

EP B1 Publication Date:

22/01/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

17/07/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/01/2025

 

 

Name:

MEDINCELL S.A.

Address:

3 Rue des Frères Lumière, 34830 Jacou, France (FR)

Agent

Name:

ARONOVA S.A.

From:

10/03/2025

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

ABBASSI, Myriam

Address:

France (FR)

2

Name:

RECH, Anthony

Address:

France (FR)

3

Name:

CROS, Jean-Manuel

Address:

France (FR)

4

Name:

ROBERGE, Christophe

Address:

France (FR)

5

Name:

LÓPEZ-NORIEGA, Adolfo

Address:

France (FR)

6

Name:

SERINDOUX, Juliette

Address:

France (FR)

7

Name:

PETIT, Audrey

Address:

France (FR)

8

Name:

PEBREL, Lea

Address:

France (FR)

Priority

Priority Number:

201762533370 P

Priority Date:

17/07/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/06; A61K 31/445; A61K 31/519; A61K 31/7048; A61K 38/08; A61K 47/34; A61K 31/5415; C08G 63/664; C08L 67/04;

Publication

European Patent Bulletin

1

Issue number:

202504

Publication date:

22/01/2025

Description:

Grant (B1)

2

Issue number:

202509

Publication date:

26/02/2025

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

24/07/2025

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

CLARIVATE IP SERVICES LIMITED

Filing date	Document type	Number of pages
10/03/2025	Power Of Attorney	1
11/03/2025	Outgoing Correspondence	1